Uridine triacetate for severe 5-fluorouracil toxicity in a patient with thymidylate synthase gene variation: Potential pharmacogenomic implications

Adverse drug reactions can be unpredictable. However, pharmacogenomic testing can help identify patients who may be more susceptible to the toxic effects of certain drugs. Genetic variations in the dihydropyrimidine dehydrogenase and thymidylate synthase genes have been shown to increase the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldeo, Candice, Vishnu, Prakash, Mody, Kabir, Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041857/
https://www.ncbi.nlm.nih.gov/pubmed/30013790
http://dx.doi.org/10.1177/2050313X18786405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041857/
https://www.ncbi.nlm.nih.gov/pubmed/30013790
http://dx.doi.org/10.1177/2050313X18786405

Ejemplares similares